News

Telerx Completes Acquisition of C3i

Telerx Completes Acquisition of C3i to Enhance Pharmaceutical Solutions Services and Global Capabilities HORSHAM, Pa. (June 30, 2014) – Telerx, a leader in U.S. customer care services, today announced that it has completed its acquisition of C3i, a leading provider of technology support services for the life sciences industry. This acquisition will provide Telerx with…

Read more

News

Telerx Expert Weighs in on FDA Social Media Regs in PharmaVoice

Kim Radefeld, our Senior Director, Healthcare Solutions, weighed in on the FDA guidance on Social Media, expected this July, for the latest edition of PharmaVoice magazine. In it she explains, “Consumers in general choose to live many aspects of their lives on social media and have become very comfortable interacting with brands on those platforms,…

Read more

News

Telerx to Acquire C3i, Adding Global Capabilities

Telerx to Acquire C3i, a Life Science Technology Services and Solutions Provider, Adding Global Capabilities HORSHAM, Pa., May 27 – Telerx, a leader in U.S. customer care services, today announced that it has signed an agreement to acquire C3i, a leading provider of technology support services for the life sciences industry. This acquisition will add…

Read more

News

Bart Cobert Recognized by DIA

Pharmacovigilance expert, and Telerx blogger, Bart Cobert, has been recognized by the Drug Information Association (DIA) for his ‘thoughtful commentary’ on the DIA’s What Lies Ahead document. Check out the full post on DIA’s Collaborate to Innovation, Official Blog of DIA’s Therapeutic Innovation & Regulatory Science Journal. You can find more drug safety insights from…

Read more